Literature DB >> 3965141

Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2.

M S Lan, O J Finn, P D Fernsten, R S Metzgar.   

Abstract

This work describes the molecular properties of a human pancreatic adenocarcinoma-associated mucin-like antigen defined by a murine monoclonal antibody (DU-PAN-2). DU-PAN-2 antigen is a large molecule, readily detected in the body fluids of patients with pancreatic adenocarcinoma and sensitive to neuraminidase treatment and alkaline reduction. The antigen binding activity of the DU-PAN-2 immunoglobulin M antibody is markedly reduced when coupled to an insoluble matrix. Therefore, the antigen was partially purified from the serum and ascites of patients with pancreatic adenocarcinoma by ammonium sulfate fractionation and Affi-Gel-Blue chromatography to remove most of the serum proteins. Noncovalently associated proteins were further separated on CsCl/CsBr density gradients and noncovalently associated lipids removed by organic solvent extraction. DU-PAN-2 antigen was monitored by a solid-phase competition radioimmunoassay. We have been able to detect antigen reactivity and analyze its electrophoretic pattern following transfer from 1% agarose gel onto nitrocellulose paper and immunoblotting with DU-PAN-2 antibody. Antigen was also labeled metabolically with various radioactive monosaccharides and sulfates. Radioimmunoprecipitation of labeled antigen with DU-PAN-2 antibody showed two distinct broad antigen bands consistent with the immunoblotting signals. The heavily glycosylated and polydisperse nature of this antigen and the results of various enzyme treatments suggest that the DU-PAN-2 epitope is expressed on a mucin-like molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965141

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

Review 1.  A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.

Authors:  Olivera J Finn
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Co-expression of X-hapten-like antigen and antigen YH206 on mucin molecules.

Authors:  Y Hinoda; K Imai; T Ban; F Itoh; A Yachi
Journal:  Gastroenterol Jpn       Date:  1991-02

3.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Authors:  D L Barnd; M S Lan; R S Metzgar; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.

Authors:  H Takasaki; E Uchida; M A Tempero; D A Burnett; R S Metzgar; P M Pour
Journal:  Int J Pancreatol       Date:  1987 Oct-Dec

5.  Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

Authors:  M Hareuveni; C Gautier; M P Kieny; D Wreschner; P Chambon; R Lathe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 6.  Human Tumor Antigens Yesterday, Today, and Tomorrow.

Authors:  Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2017-05       Impact factor: 11.151

7.  Carcinoma of the pancreas. Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody.

Authors:  D M Mahvi; W C Meyers; R C Bast; H F Seigler; R S Metzgar
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

8.  Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.

Authors:  Neeley Remmers; Judy M Anderson; Erin M Linde; Dominick J DiMaio; Audrey J Lazenby; Hans H Wandall; Ulla Mandel; Henrik Clausen; Fang Yu; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

9.  Specific chromosomal abnormalities characterize four established cell lines derived from malignant human gliomas.

Authors:  S H Bigner; H S Friedman; J A Biegel; C J Wikstrand; J Mark; R Gebhardt; L F Eng; D D Bigner
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Radioimmunodetection of human pancreatic tumor xenografts using DU-PAN II monoclonal antibody.

Authors:  K Nakamura; A Kubo; S Hashimoto; T Furuuchi; H Takami; O Abe
Journal:  Ann Nucl Med       Date:  1988-05       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.